# Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence

> **NCT01468012** · PHASE2,PHASE3 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 23 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** levodopa carbidopa and entacapone (LCE)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01468012
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-07
- **Final completion:** 2015-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468012, "Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01468012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*